Mercer Global Advisors
ABEO icon

Mercer Global Advisors’s Abeona Therapeutics ABEO Stock Holding History

Mercer Global Advisors’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.3K Buy
+3,608
New +$19.8K ﹤0.01% 4765

Other funds holding ABEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mercer Global Advisors's ABEO Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 3,608 shares worth $22.3K. The stake represents ﹤0.01% of the portfolio and ranks #4765 among its holdings.

95 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Mercer Global Advisors held 3,608 shares of Abeona Therapeutics worth $22.3K as of Q2 2026.
  • Abeona Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Abeona Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4765 holding.
  • 95 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.